Recommendation of first chikungunya vaccine for persons as young as 12 years old expands access for US travelers to regions with outbreak or ...

The CDC's Advisory Committee on Immunization Practices (ACIP) unanimously recommended that U.S. travelers ages 12 years and ...

Discover how a structural breakthrough in the chikungunya virus is opening new avenues for antiviral drug development and ...

A disabling mosquito-borne disease called chikungunya has killed six people in the French Indian Ocean island of La Reunion ...

Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age ...

Chikungunya, caused by its namesake virus ... travel between mainland France and La Réunion, there is a risk of transmission back to France and even to other French overseas territories.

A panel of federal health experts on Wednesday recommended expanded vaccine options for several diseases, including ...

Chikungunya appears four to eight days after a mosquito ... and the recent rainfall has increased mosquito density, raising the risk of transmission. The public is requested to remain vigilant, ...

Similar to the 2005-2006 chikungunya outbreak, there is a risk of transmission to mainland France and other French overseas territories. Local authorities of La Réunion have published a Level 4 ...

With this extension, IXCHIQ ®, the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 years of age and older in the European Union (EU).

if traveling to an area where there has been evidence of chikungunya transmission within the past 5 years. The approval of Vimkunya was based on data from two phase 3 studies that assessed the ...